Picture loading failed.

Anti-TNFSF13B therapeutic antibody (Pre-made Belimumab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Belimumab, sold under the brand name Benlysta, is a human monoclonal antibody that inhibits B-cell activating factor (BAFF), also known as B-lymphocyte stimulator (BLyS). It is approved in the United States, Canada, and the European Union to treat systemic lupus erythematosus (SLE).

Order informatioin

Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-056-1mg 1mg 3090
GMP-Bios-ab-056-10mg 10mg 21890
GMP-Bios-ab-056-100mg 100mg 148000
GMP-Bios-ab-056-xmg ≥100mg Inquiry
Shipping Cost: 760.00


Products Name (INN Index) Anti-TNFSF13B therapeutic antibody (Pre-made Belimumab biosimilar,Whole mAb)
INN Name Belimumab
FormatWhole mAb
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCLambda
Highest_Clin_Trial (Jan '20)Approved
Est. StatusActive
100% SI Structure5y9k:HL/5y9j:HL/6fxn:OP:QR:MN:FG:HI:DE
99% SI StructureNone
95-98% SI Structure6erx:HI:DE:QR:MN:FG:OP
Year Proposed2003
Year Recommended2004
CompaniesAssistance Publique Hopitaux de Paris;Cancer Trials Australia;GlaxoSmithKline;Hospital for Special Surgery;Human Genome Sciences;North Shore-Long Island Jewish Health System;University of Alabama at Birmingham;University of Pennsylvania;University of Wisconsin-Madison;Washington University School of Medicine;Cambridge Antibody Technology
Conditions ApprovedSystemic lupus erythematosus;Lupus nephritis
Conditions ActiveAnti-neutrophil cytoplasmic antibody-associated vasculitis;Myositis;Emphysema;Membranous glomerulonephritis;Myasthenia gravis;Renal transplant rejection;Systemic scleroderma;Graft-versus-host disease
Conditions DiscontinuedWaldenstrom's macroglobulinaemia;Rheumatoid arthritis;Sjogren's syndrome
Development TechCAT Phage Display